XML 55 R42.htm IDEA: XBRL DOCUMENT v3.21.1

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)

12 Months Ended

Apr. 03, 2021

Segment Reporting [Abstract]

Selected Information by Business Segment

(In thousands)			2021						2020						2019
Net revenues
Plasma			$	333,334					$	460,637					$	426,781
Blood Center			307,370						325,661						335,557
Hospital			210,606						194,604						190,821
Net revenues by business unit			851,310						980,902						953,159
Service (1)			20,758						19,830						19,906
Effect of exchange rates			(1,605)						(12,253)						(5,486)
Net revenues			$	870,463					$	988,479					$	967,579
(1) Reflects revenue for service, maintenance and parts.

(In thousands)			2021						2020						2019
Segment operating income
Plasma			$	172,463					$	225,351					$	180,300
Blood Center			141,962						159,802						163,628
Hospital			84,066						80,669						76,338
Segment operating income			398,491						465,822						420,266
Corporate expenses (1)			(256,751)						(255,727)						(263,603)
Effect of exchange rates			12,830						7,920						8,367
Deal amortization			(32,830)						(25,746)						(24,803)
Impairment of assets, PCS2 accelerated depreciation and other related charges			(25,696)						(75,750)						(40,296)
Transaction and Integration costs			(18,421)						(568)						—
Restructuring and turnaround costs			(15,661)						(19,878)						(13,660)
European Medical Device Regulation costs and other			(4,130)						(1,506)						—
Litigation-related charges			(897)						701						(2,726)
Gains on divestitures and sale of assets			32,812						8,083						—
Operating income			$	89,747					$	103,351					$	83,545
(1) Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.

(In thousands)			2021						2020						2019
Depreciation and amortization
Plasma			$	24,093					$	63,347					$	61,721
Blood Center			39,672						38,429						38,074
Hospital			20,522						8,513						9,623
Total depreciation and amortization (excluding impairment charges)			$	84,287					$	110,289					$	109,418

(In thousands)			April 3, 2021						March 28, 2020						March 30, 2019
Long-lived assets(1)
Plasma			$	105,599					$	141,903					$	192,628
Blood Center			83,225						93,758						127,272
Hospital			28,735						17,738						24,079
Total long-lived assets			$	217,559					$	253,399					$	343,979
(1) Long-lived assets are comprised of property, plant and equipment.

Selected information by principle operating regions is presented below:

(In thousands)			April 3, 2021						March 28, 2020						March 30, 2019
Long-lived assets(1)
United States			$	159,749					$	186,488					$	269,849
Japan			1,515						2,037						1,726
Europe			10,384						10,143						11,200
Asia			30,588						29,175						30,930
Other			15,323						25,556						30,274
Total long-lived assets			$	217,559					$	253,399					$	343,979
(1) Long-lived assets are comprised of property, plant and equipment.

(In thousands)			2021						2020						2019
United States			$	522,607					$	646,204					$	606,845
Japan			77,676						72,218						69,908
Europe			159,077						153,347						164,504
Asia			105,820						109,295						118,700
Other			5,283						7,415						7,622
Net revenues			$	870,463					$	988,479					$	967,579

Schedule of Revenues by Product Line

Net revenues by product line are as follows:

(In thousands)			2021						2020						2019
Plasma products and services			414,266						537,231						501,837
Blood Center products and services			239,614						252,829						269,203
Hospital products and services			216,583						198,419						196,539
Net revenues			$	870,463					$	988,479					$	967,579

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration